Search research articles
Contact Us
Filters
Showing results (121-130 of 170) with videos related to
Page
of 17
Sort By:
American Journal of Clinical Oncology
|
June 3, 2009
Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapy
Pierre Fumoleau, Hernan Cortés-Funes, Amina B Taleb, et al.
Experimental Gerontology
|
November 30, 2010
The effect of α-actinin-3 deficiency on muscle aging
Jane T Seto, Stephen Chan, Nigel Turner, et al.
ACS Pharmacology & Translational Science
|
November 15, 2021
Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2
Ke Liu, Rongfeng Zou, Wenqiang Cui, et al.
Nature Communications
|
November 15, 2017
GyrI-like proteins catalyze cyclopropanoid hydrolysis to confer cellular protection
Hua Yuan, Jinru Zhang, Yujuan Cai, et al.
Journal of the National Cancer Institute
|
September 27, 2014
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer
Lawrence Fong, Peter Carroll, Vivian Weinberg, et al.
Molecular Microbiology
|
March 24, 2006
5'-Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice
Ryan H Senaratne, A Dharshan De Silva, Spencer J Williams, et al.
Oncogene
|
March 6, 2021
Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers
Reem Ali, Adel Alblihy, Islam M Miligy, et al.
Neurology
|
July 31, 2012
MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study
Shlomo Shinnar, Jacqueline A Bello, Stephen Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2003
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial
Jean-Marc Nabholtz, Carla Falkson, Daniel Campos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer
Luca Gianni, Gilles H Romieu, Michail Lichinitser, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 170) with videos related to
Sort By:
Page
of 17
American Journal of Clinical Oncology
|
June 3, 2009
Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapy
Pierre Fumoleau, Hernan Cortés-Funes, Amina B Taleb, et al.
Experimental Gerontology
|
November 30, 2010
The effect of α-actinin-3 deficiency on muscle aging
Jane T Seto, Stephen Chan, Nigel Turner, et al.
ACS Pharmacology & Translational Science
|
November 15, 2021
Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2
Ke Liu, Rongfeng Zou, Wenqiang Cui, et al.
Nature Communications
|
November 15, 2017
GyrI-like proteins catalyze cyclopropanoid hydrolysis to confer cellular protection
Hua Yuan, Jinru Zhang, Yujuan Cai, et al.
Journal of the National Cancer Institute
|
September 27, 2014
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer
Lawrence Fong, Peter Carroll, Vivian Weinberg, et al.
Molecular Microbiology
|
March 24, 2006
5'-Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice
Ryan H Senaratne, A Dharshan De Silva, Spencer J Williams, et al.
Oncogene
|
March 6, 2021
Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers
Reem Ali, Adel Alblihy, Islam M Miligy, et al.
Neurology
|
July 31, 2012
MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study
Shlomo Shinnar, Jacqueline A Bello, Stephen Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2003
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial
Jean-Marc Nabholtz, Carla Falkson, Daniel Campos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer
Luca Gianni, Gilles H Romieu, Michail Lichinitser, et al.
Page
of 17